Skip to main content
. 2023 May 5;10:1182094. doi: 10.3389/fsurg.2023.1182094

Table 3.

Outcome.

Outcome
Persistent leak after VACStent treatment 12/40
 Healing after further treatments 4
 No healing 8
Complete closure 32/40 (80%)
Postoperative morbidity-AL rate, n 1/10
Sepsis progression, n 1/50
Death due to tumor situation, n 3/50